Treatment of HCV infected patients with cirrhosis
US11690860B2 · kind B2 · utility
1Cited by
199References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2020 |
| Grant date | Jul 4, 2023 |
| Priority date | — |
| Expiry date | Oct 7, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition that includes a compound of the structure: to treat an HCV infected patient with cirrhosis, and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.